The global platelet-rich plasma industry continues to soar, with estimations pegging its value at an impressive US$ 416.61 billion in 2023. Projections indicate a robust upward trajectory, foreseeing the market to surge to US$ 746.09 billion by 2033, boasting a noteworthy Compound Annual Growth Rate (CAGR) of 6% during the forecast period. Platelet-rich plasma (PRP) …
Category Archives: Healthcare Trends
Global Revision Knee Replacement Industry Poised to Reach US$2 Billion by 2032 with a Remarkable 4.1% CAGR | Unveils FMI Insights
The Global Revision Knee Replacement Industry is set to witness a remarkable surge, with projections indicating a substantial leap from the current valuation of US$1.3 billion in 2022 to an anticipated US$2 billion by 2032. This robust growth is underscored by a compound annual growth rate (CAGR) of 4.1%, reflecting the market’s resilience and potential. Revision knee …
Global Kidney Stone Extraction Balloon Industry Poised for a Meteoric Rise to US$902.2 Million by 2032, Sustained by a Robust 6.5% CAGR | FMI
The Global Kidney Stone Extraction Balloon Industry is set to soar, projecting a robust 6.5% Compound Annual Growth Rate (CAGR) from 2022 to 2032. Starting at US$ 450.5 million in 2022, the industry is expected to reach a staggering US$ 902.2 million by 2032. This remarkable growth is primarily driven by the escalating incidence of kidney stones, …
Global MRI-Safe CRT Devices Industry on Track for 9.6% CAGR Ascendancy, Set to Hit US$ 1511 Million by 2032 | FMI
The Global MRI-Safe CRT Devices Industry which was worth US$ 550.5 million in 2022, is estimated to be worth US$ 1511 million by 2032, growing at a CAGR of 9.6% during the forecast period. Increasing incidences of heart failure, which leads to increased hospitalizations, as well as a variety of other issues, are projected to drive up demand for MRI-safe CRT systems. Global …
Global Airway Disease Treatment Industry on Track for Exceptional $3,495.3 Million Revenue by 2032 | FMI
The Global Airway Disease Treatment Industry is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period. LABA-ICS, LAMA-ICS, triple treatment, and other related drugs are among the pharmaceuticals used in combination therapy for COPD. Combination therapy is gaining popularity due to its greater efficacy …
Global Hepatitis C Virus (HCV) Testing Industry Set to Soar at 5.4% CAGR, Anticipated to Reach US$1.3 Billion by 2033 | Unveils FMI Analysis
Anticipated to reach a total value of US$ 785.3 million by the conclusion of 2023, the Global Hepatitis C Virus Testing Industry is poised for substantial growth. Projections for the period spanning 2023 to 2033 indicate a noteworthy Compound Annual Growth Rate (CAGR) of 5.4%, with the market expected to culminate at a valuation of US$ …
Global Postpartum Depression Management Industry Poised to Surpass US$ 173.9 Million by 2032 with a Remarkable 3.8% CAGR | Reports FMI
Postpartum depression, a prevalent mood disorder observed primarily in expectant mothers but affecting both genders, arises following childbirth. A recent study in a peer-reviewed journal revealed that one in seven women who have recently given birth experiences this condition. Within three weeks of childbirth, the symptoms of depression often become pronounced. In 2022, the Global Postpartum …
Global Pharmacy Refrigerators Industry Set to Skyrocket at a 5.8% CAGR, Anticipated to Reach US$ 1.03 Billion by 2032 | FMI
The Global Pharmacy Refrigerators Industry exhibited a value of US$ 552.3 Million in 2022, and it’s poised for remarkable growth, projected to soar to US$ 1.03 Billion by 2032, marking an impressive CAGR of 5.8% during the 10 years. In an era marked by an escalating prevalence of chronic diseases and a surge in organ transplant procedures, the …
Global Home Dialysis Systems Industry Poised for Astounding US$ 45.81 Billion by 2032, Driven by 10.1% CAGR | FMI
The Global Home Dialysis Systems Industry is expected to grow at a CAGR of 10.1% and reach a valuation of USD 45.81 Bn by 2032, with a revenue of USD 19.27 Bn in 2022. A growing number of diabetic and hypertension patients and an increasing geriatric population coupled with government initiatives investing huge amounts of capital in the development of new products are …
Rare Neurological Disease Treatment Market Aims for a US$ 19.795 Billion Horizon by 2032-FMI Study
The majority of rare diseases currently have no or few effective diagnostic and treatment procedures, which can be attributed in part to a lack of funding for research on rare disease pathogenesis and a lack of representative patients. rare neurological disease treatment industry are one of the most common types of rare diseases, with ineffective diagnoses and …